Global Aquaculture Vaccines Market - 2022-2029

Market Overview

Aquaculture Vaccines Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

A protective immune response is created in an animal during vaccination through administering vaccinations. Antigens from pathogenic organisms that have been turned non-pathogenic through various processes are used in vaccines to stimulate the animal's immune system and raise its resistance to disease when pathogens are met naturally. Vaccination is an easy, effective and preventive method of protecting fish from diseases.

Market Dynamics

Innovation in aquaculture vaccines is expected to drive market growth.

Due to its technological advancements, Elanco has created a new class of salmon virus vaccinations known as nucleic acid vaccines. These immunizations provide a more focused method for protecting salmon from viral infections. Only the relevant genetic elements of the pathogen that cause the formation of an antigen are present in nucleic acid vaccines. These elements are placed into a plasmid, a circular nucleic acid structure, which, when injected into a muscle, instructs cells to manufacture antigens in a manner that resembles the immunological response to a genuine infection. Nucleic acid vaccines do not risk spreading the illness because they only contain a small portion of the virus.

Moreover, according to the global seafood alliance, Plant-based fish vaccines could provide low-cost, high safety and effective protection for farmed fish species. The viability, effectiveness, and safety of plant factories for vaccines have been demonstrated in several pre-clinical and clinical trials. A plant-based platform offers attractive benefits for recombinant subunit vaccines. The safety issues with live vaccinations are not present with plant-based vaccines. In contrast to mammalian-based production systems, undesirable or harmful components, such as bacterial toxins and undesired proteins from yeast, have not been discovered in plant-derived systems. Like naturally occurring systems, plant-based systems have a high capacity for biosynthesis, which boosts the immunogenicity of vaccines. Oral vaccinations made from plants are the best. The production procedure is straightforward, and injection does not require the use of any additional medical equipment. High purity plant-based vaccines make vaccination more convenient and boost immune responses. When vaccine antigens are consumed orally, they pass past the stomach and are absorbed in the intestine, triggering immunological reactions. Fish raised on farms could be protected with low-cost, highly safe, and efficient plant-based vaccinations. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

Stringent regulatory policies for the manufacturing and approving of aquaculture vaccines and complicated vaccine development approaches are some factors the market is expected to hamper the market growth in the forecast period.

Industry Analysis

The aquaculture vaccines market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has positively impacted healthcare systems and the market. Aquaculture farmers have implemented conservative stocking strategies to lessen their exposure to COVID-19 hazards and prevent financial losses in the face of declining pricing, which is expected to result in a 1.3 percent decrease in total output in 2020. Although this number hasn't been verified, it would represent the first yearly fall in worldwide aquaculture production in nearly 60 years and a striking break from the steady 4-5 percent pace of growth seen over the past few years. However, due to the variations in growth rates, lengths of production cycles, and market demands, the impact's intensity and the producers' response have varied greatly depending on the species. It's also crucial to understand that market supply for some aquacultured species may take some time to change after early production process disturbances. Additionally, the decrease in aquaculture vaccine manufacturing caused by the reduced workforce combined with changing trends to produce a vaccine for COVID-19 infection has also impacted the market. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Inactivated Vaccines segment is expected to hold the largest market share in aquaculture vaccines market

The inactivated vaccines segment is expected to dominate in 2021. The segment benefits because the process of killing a pathogen that is cultivated and then turned into a vaccine is used to create inactivated vaccinations, also referred to as killed vaccines. These vaccines are the ones that are typically used to prevent various bacterial and viral infections. Moreover, Strong immune responses are produced by inactivated vaccines by keeping the inactive genetic component, and the virus surface exposed antigens are crucial for a strong immune response. Additionally, since inactivated vaccination does not persist in the environment or in the fish that have received it, it is safe, which increases demand. Although regular dosages are necessary, there is very little possibility of a pathogen returning or interfering with the system. One of the most widely used vaccines that are also legally and commercially available is inactivated vaccines. Certain vaccines are available for disorders, including infectious salmon anemia and infectious pancreatic virus, among others. Therefore, it has increased the demand for inactivated aquaculture vaccines. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global aquaculture vaccines market

In 2021, North America accounted for the highest revenue share. The market's increasing research and development investment, government support for aquaculture vaccine development, product launches and acquisitions by the key regional players are some of the factors the market is expected to boost in the forecast period. For instance, the University of Florida received planting solutions grant from the Foundation for Food & Agriculture Research (FFAR) in February 2021 for around USD 790,326. The goal of this investment was to aid in the creation of a vaccine delivery method that will stop the tilapia lake virus and other diseases from spreading inside the aquaculture sector. Moreover, in July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC. This added to the company's Pharmaq business, which is involved in fish vaccines and services. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the aquaculture vaccines market are Merck & Co., Inc., Tecnovax, Hipra, Zoetis LLC, Phibro Animal Health Corporation, Elanco, KBNP, INC., Kyoto Biken Laboratories, Inc., Veterquimica S.A., Virbac S.A.

Merck & Co., Inc.:

Overview:

Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biological therapies and animal health products. The company's operations are principally managed on a product basis and include two operating segments, the pharmaceutical and animal health segments, both reportable. The company offers vaccinations, poultry, cattle, and aquaculture products, among other animal health items. Merck provides managed healthcare services to hospitals, government organizations, wholesalers, retailers, and hospitals. It also provides veterinarians, distributors, and animal producers with animal health products. The company and its subsidiaries operate in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Outside of North America and Canada, Merck is known as MSD, and its global headquarters are in Kenilworth, New Jersey.

roduct Portfolio:

AQUAVAC IridoV: AQUAVAC IridoV, an oil-adjuvanted vaccine, is administered intraperitoneally as a single-injection dose to fish weighing no less than 5 grams. Fish susceptible to this disease include species such as Asian seabass, grouper, pompano and Japanese yellowtail.

The global aquaculture vaccines market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.